
04/08/2025
Last week at Angels for Change’s SummitONE, leaders from across the pharmaceutical supply chain gathered to advance a shared mission: ending drug shortages and ensuring patients have reliable access to essential medicines.
As last year’s host, Fresenius Kabi symbolically passed the baton to McKesson for this year’s event, underscoring the ongoing collaboration needed to strengthen supply resiliency.
During the Executive Champions Panel, Fresenius Kabi USA’s President, Arun Verma, joined Kirk Kaminsky of McKesson and Rich Tremonte of Cencora—founding pilot members of Project GOLD (Generic Oncology Lifesaving Drugs)—to discuss their roles in this new resiliency program, which establishes an onshore buffer supply of six essential medications used to treat cancer.
Arun also emphasized how Fresenius Kabi’s investments in expanding and automating U.S. manufacturing facilities are making an impact.
Ending drug shortages requires unwavering dedication from everyone in the industry, because timely access to medicines is essential to every patient’s health.